Search - tctmd.com

Displaying 81 - 100 of 116

Sort: Relevancy | Date

Presentation THT 2023

Novel applications for counterpulsation

Presenter: Ran Lee

March 21, 2023

Presentation THT 2023

Predictors for a positive hemodynamic & clinical response to intra-aortic counterpulsation

Presenter: A. Reshad Garan

March 21, 2023

Presentation THT 2023

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

Presenter: Rachna Kataria

March 21, 2023

Presentation THT 2023

Principles and unique physiological effects characteristic of counterpulsation

Presenter: Arvind Bhimaraj

March 21, 2023

Presentation THT 2023

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Presenter: Jonathan Menachem

March 20, 2023

Presentation TCT 2022

Distal Limb Protection During MCS: Balancing Risk and Benefit

Presenter: Jose Wiley

September 19, 2022

Presentation TCT 2022

Update From the AHA Expert Consensus Document: When/How to De-escalate MCS

Presenter: Ajar Kochar

September 19, 2022

Presentation TCT 2022

Update From the AHA Expert Consensus Document: When/How to Escalate MCS

Presenter: Gregory Serrao

September 19, 2022

Presentation TCT 2022

Is There a Role for MCS in Massive PE and Which Modality?

Presenter: Andrew Klein

September 19, 2022

Presentation TCT 2022

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Presenter: Adam Salisbury

September 18, 2022

Presentation TCT 2022

MCS Initiation - Fuel Injection or Plug In the Pump?: Pharmacological vs. Mechanical Support

Presenter: Jeffrey Shih

September 16, 2022

Presentation TCT 2022

Impella Regret: Case-based Advancement in MCS Decision-Making and Execution

Presenter: Nathan Masterson

September 16, 2022

Presentation TVT 2022

CLIP-PELLA: "New School" Shock Management – Post-STEMI With MCS-guided Mitral TEER + PCI

Presenter: Thomas Waggoner

June 08, 2022

Presentation ARCH 2022

Temporary MCS as a Bridge to Heart Transplantation

Presenter: Joel Schilling

April 23, 2022

Presentation CTO 2022

The Challenge of High Risk Anatomy - Risk Stratification for MCS in Complex PCI - Case and Review of Literature

Presenter: Mitul Patel

February 25, 2022

Presentation CTO 2022

Calcium Modification in a LM Trifurcation of an ACS Patient with MCS

Presenter: Robert Riley

February 25, 2022

Presentation TCT 2021

The Role of MCS Assisted With Catheter Directed Therapy

Presenter: Sanjum Sethi

November 06, 2021

Presentation TCT 2021

Con: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Presenter: Sandeep Nathan

November 05, 2021

Presentation TCT 2021

Pro: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Presenter: Arthur Reshad Garan

November 05, 2021

Presentation TCT 2020

What Clinical Trials Are Needed to Support MCS in the Modern Era?

Presenter: Gregg Stone

October 16, 2020

Advertisement

Novel applications for counterpulsation

Predictors for a positive hemodynamic & clinical response to intra-aortic counterpulsation

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

Principles and unique physiological effects characteristic of counterpulsation

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Distal Limb Protection During MCS: Balancing Risk and Benefit

Update From the AHA Expert Consensus Document: When/How to De-escalate MCS

Update From the AHA Expert Consensus Document: When/How to Escalate MCS

Is There a Role for MCS in Massive PE and Which Modality?

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

MCS Initiation - Fuel Injection or Plug In the Pump?: Pharmacological vs. Mechanical Support

Impella Regret: Case-based Advancement in MCS Decision-Making and Execution

CLIP-PELLA: "New School" Shock Management – Post-STEMI With MCS-guided Mitral TEER + PCI

Temporary MCS as a Bridge to Heart Transplantation

The Challenge of High Risk Anatomy - Risk Stratification for MCS in Complex PCI - Case and Review of Literature

Calcium Modification in a LM Trifurcation of an ACS Patient with MCS

The Role of MCS Assisted With Catheter Directed Therapy

Con: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

Pro: Is Impella CP the First-line MCS of Choice for Acute MI and Cardiogenic Shock?

What Clinical Trials Are Needed to Support MCS in the Modern Era?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content